Area of research
Cancer Research · Genetics
Research interest
Research interests include Cancer Genomics and Diagnostics, Breast Cancer Treatment Studies, Estrogen and related hormone effects, and HER2/EGFR in Cancer Research.
Advancing biological understanding of cellular senescence with computational multiomics
Advancing biological understanding of cellular senescence with computational multiomics.
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenase
Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.
Spatial mapping of cellular senescence: emerging challenges and opportunities
Author Correction: Pan-cancer analysis of whole genomes
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
A common IGF1R gene variant predicts later life breast cancer risk in women with preeclampsia.
NIH SenNet Consortium to map senescent cells throughout the human lifespan to understand physiological health
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial
Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.
Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden
Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.
Correction to: N-Propargylglycine: a unique suicide inhibitor of proline dehydrogenase with anticancer activity and brain-enhancing mitohormesis properties.
Pan-cancer analysis of whole genomes
Comprehensive molecular characterization of mitochondrial genomes in human cancers
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer
Divergent mutational processes distinguish hypoxic and normoxic tumours
A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population.
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
Pregnancy Hypertension and a Commonly Inherited IGF1R Variant (rs2016347) Reduce Breast Cancer Risk by Enhancing Mammary Gland Involution.
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
The chromatin accessibility landscape of primary human cancers
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
Abstract 4864: Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades